(Q36972097)

English

Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor

scientific article published on 02 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Emiliano Cocco

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Joyce Varughese

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Natalia Buza

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stefania Bellone

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ken-Yu Lin

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Marta Bellone

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Paola Todeschini

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dan-Arin Silasi

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Masoud Azodi

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Peter E Schwartz

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Thomas J Rutherford

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Luisa Carrara

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Renata Tassi

13

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sergio Pecorelli

14

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Charles J Lockwood

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Alessandro D Santin

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 July 2011

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Clinical & Experimental Metastasis

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

28

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

689-700

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

CD59 silencing via retrovirus-mediated RNA interference enhanced complement-mediated cell damage in ovary cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

High incidence of silent venous thromboembolism before treatment in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Complement function in mAb-mediated cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Molecular targeting of angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Angiogenesis in epithelian ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Mechanisms of normal and tumor-derived angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

29 September 2017

Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

27 June 2018

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

4 September 2018

Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

4 September 2018

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697933

4 September 2018

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced stage transitional cell carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue factor and PAR signaling in tumor progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of tissue factor in prostate cancer correlates with malignant phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21725665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10585-011-9401-0

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36972097&oldid=2199662950"